In light of this finding, its effect on c-Myc was examined, demonstrating that MEG3 downregulates c-Myc activity by promoting c-Myc degradation through ubiquitination and therefore inhibits glycolysis in CRC [57]. The gene discussed is MEG3; the disease is colorectal carcinoma.